Filter
1298
Filtered Results: 1298
Text search:
BMJ
Featured
Recommendations
120
New Publications
164
Language
Document type
No document type
431
Studies & Reports
415
Guidelines
270
Manuals
69
Fact sheets
47
Strategic & Response Plan
22
Training Material
18
Resource Platforms
10
Situation Updates
9
Infographics
3
Online Courses
3
Brochures
1
Countries / Regions
Global
54
Brazil
41
Latin America and the Carribbean
36
Russia
36
Africa
28
India
27
Western and Central Europe
27
South Africa
26
Ukraine
21
Kenya
19
Germany
16
Mozambique
16
Eastern Europe
16
Ethiopia
15
Uganda
15
Syria
15
Malawi
15
Sierra Leone
13
Middle East and North Africa
13
Congo, Democratic Republic of
12
Eastern Europe and Central Asia
12
Rwanda
11
Bangladesh
11
Liberia
10
Nepal
10
Colombia
10
Burkina Faso
9
Nigeria
9
Peru
9
Angola
9
West and Central Africa
8
Guinea-Bissau
7
Indonesia
7
Yemen
7
East and Southern Africa
7
Guinea
6
Argentina
6
Ecuador
6
Myanmar / Burma
6
Chile
6
South–East Asia Region
6
Asia
6
United Kingdom
6
Senegal
5
Zimbabwe
5
South Sudan
5
Tanzania
5
Philippines
4
Pakistan
4
Zambia
4
Vietnam
4
Spain
4
Ghana
3
Somalia
3
China
3
Sudan
3
Sri Lanka
3
Western Pacific Region
3
Paraguay
3
Portugal
3
Mali
2
Cameroon
2
Lebanon
2
Turkey
2
Cambodia
2
Thailand
2
Benin
2
Botswana
2
Italy
2
Tajikistan
2
Kyrgyzstan
2
Kazakhstan
2
North America
2
France
2
Israel
2
Bosnia and Herzegovina
2
Iraq
1
Jordan
1
Afghanistan
1
Egypt
1
Mauritania
1
Papua New Guinea
1
Central African Republic
1
El Salvador
1
Madagascar
1
Lesotho
1
Mexico
1
Bhutan
1
Venezuela
1
North Korea
1
Albania
1
Southern Africa
1
Laos
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Moldova
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
362
Clinical Guidelines
126
Public Health
93
Women & Child Health
79
Key Resources
27
Capacity Building
9
Pharmacy & Technologies
5
Toolboxes
COVID-19
307
Mental Health
124
HIV
94
TB
79
NCDs
77
Caregiver
65
Planetary Health
57
AMR
48
NTDs
29
Ebola
27
Global Health Education
27
Refugee
21
Disability
20
Conflict
20
Pharmacy
20
Health Financing Toolbox
17
Rapid Response
15
Zika
13
Polio
8
Cholera
6
Natural Hazards
5
Specific Hazards
5
Social Ethics
4
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
Four initiatives have estimated the value of aid for reproductive, maternal, newborn, and child health
(RMNCH): Countdown to 2015, the Institute for Health Metrics and Evaluation (IHME), the Muskoka Initiative, and
the Organisation for Economic Co-operation and Development (OECD) policy marker. We...
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO Regional Director for Europe said at the launch ev...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
Pregnancy and childbirth during adolescence profoundly affects the lives of millions of girls worldwide, and is a leading cause of maternal mortality and morbidity, and infant and child mortality. Every year, an estimated 21 million girls aged 15–19 years old in low- and middle-income countries be...
Unpreparedness of health professionals to address non-communicable diseases (NCD) at peripheral health facilities is a critical health system challenge in Mozambique. To address this weakness and decentralize NCD care, training of the primary care workforce is needed. We describe our experience in t...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
The guide to implementing the One Health Joint Plan of Action (OH JPA) at national level provides practical guidance on how countries can adopt and adapt the OH JPA to strengthen and support national One Health action.
Building on the OH JPA theory of change, this guide describes three pathways a...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
A year ago, the second Special Session of the World Health Assembly (WHASS) unanimously agreed to start a diplomatic process for a new binding instrument aimed at ensuring the international community is better prepared for the next health emergencies. The establishment of an Intergovernmental Negoti...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
Prevention of stroke and transient ischemic attack includes both conventional approaches to vascular risk factor management (blood pressure lowering, cholesterol reduction with statins, smoking cessation and antiplatelet therapy)
and more specific interventions, such as carotid revascularization or...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
